CLASSIFICAZIONE E PROGNOSI DELLE COMPLICANZE PERIOCULARI RELATIVE ALLA CECITA' A SEGUITO DI INIEZIONI DA FILLER
L’articolo revisiona la casistica su 9 casi di gravi complicanze sulla vista e la regione oculare in pazienti che avevano eseguito trattamenti iniettivi con diversi tipi di acido jaluronico cross linkato nell’area in oggetto.
La regione infiltrata che ha comportato maggiori problematiche è stata quella della glabella con occlusioni vascolari per coinvolgimento dell’arteria retinica centrale ( con conseguente perdita della vista ) e/o dell’arteria ciliare posteriore ( con danni corioidali).
Le complicanze relative alla vista si associano variabilmente a altre manifestazioni sintomatologiche oculari quali oftalmoplegia, ptosi e strabismo (in alcuni casi reversibili in parte o in toto ) , a differenza della cecità che permane irreversibile.
Autore del contributo di commento:
Maurizio Cavallini - Membro del Comitato Scientifico Agorà
ABSTRACT ARTICOLO ORIGINALE
OGGETTO DEL CONTRIBUTO DI COMMENTO
Plast Reconstr Surg. 2017 Jul;
140(1):61-64.
doi: 10.1097/PRS.0000000000003471.
Classification and Prognosis of Periocular Complications Related to Blindness following Cosmetic Filler Injection
Myung Y, Yim S, Jeong JH, Kim BK, Heo CY, Baek RM, Pak CS.
Common side effects during hyaluronic acid filler injections are typically mild and reversible, but several reports of blindness have received attention. The present study focused on orbital symptoms combined with blindness, aiming to classify affected patients and predict their disease course and prognosis.
From September of 2012 to August of 2015, nine patients with vision loss after filler injection were retrospectively reviewed. Ptosis, ophthalmoplegia, and enophthalmos were recorded over a 6-month follow-up, and patients were classified into four types according to periocular symptom manifestation.
Two patients were categorized as type I (blindness without ptosis or ophthalmoplegia), two patients as type II (blindness and ptosis without ophthalmoplegia), two patients as type III (blindness and ophthalmoplegia without ptosis), and three patients as type IV (blindness with ptosis and ophthalmoplegia).
The present study includes previously unpublished information about orbital symptom manifestations and prognosis combined with blindness caused by retinal artery occlusion after cosmetic filler injection.
CLINICAL QUESTION/LEVEL OF EVIDENCE:
Therapeutic, V.